688799 华纳药厂
已收盘 09-11 15:00:01
资讯
新帖
简况
华纳药厂:中信保诚基金管理有限公司、方正证券股份有限公司等多家机构于9月3日调研我司
证券之星 · 09-07
华纳药厂:中信保诚基金管理有限公司、方正证券股份有限公司等多家机构于9月3日调研我司
每周股票复盘:华纳药厂(688799)获洛索洛芬钠贴剂注册证
证券之星 · 09-06
每周股票复盘:华纳药厂(688799)获洛索洛芬钠贴剂注册证
股市必读:华纳药厂新发布《自愿披露关于子公司原料药获得上市申请批准通知书的公告》
证券之星 · 09-03
股市必读:华纳药厂新发布《自愿披露关于子公司原料药获得上市申请批准通知书的公告》
华纳药厂最新公告:子公司艾拉莫德原料药获上市批准
证券之星 · 09-02
华纳药厂最新公告:子公司艾拉莫德原料药获上市批准
股市必读:华纳药厂新发布《自愿披露关于获得药品注册证书的公告》
证券之星 · 09-02
股市必读:华纳药厂新发布《自愿披露关于获得药品注册证书的公告》
股市必读:华纳药厂新发布《自愿披露关于获得药品注册证书的公告》
证券之星 · 09-01
股市必读:华纳药厂新发布《自愿披露关于获得药品注册证书的公告》
华纳药厂最新公告:获得洛索洛芬钠贴剂药品注册证书
证券之星 · 08-31
华纳药厂最新公告:获得洛索洛芬钠贴剂药品注册证书
8月31日华纳药厂涨5.16%,安信医药健康股票A基金重仓该股
证券之星 · 08-31
8月31日华纳药厂涨5.16%,安信医药健康股票A基金重仓该股
每周股票复盘:华纳药厂(688799)Q2净利增26.16%
证券之星 · 08-30
每周股票复盘:华纳药厂(688799)Q2净利增26.16%
华纳药厂(688799)6月30日股东户数0.75万户,较上期减少9.86%
证券之星 · 08-25
华纳药厂(688799)6月30日股东户数0.75万户,较上期减少9.86%
图解华纳药厂中报:第二季度单季净利润同比增长26.16%
证券之星 · 08-25
图解华纳药厂中报:第二季度单季净利润同比增长26.16%
股市必读:华纳药厂新发布《自愿披露关于子公司原料药获得上市申请批准通知书的公告》
证券之星 · 08-25
股市必读:华纳药厂新发布《自愿披露关于子公司原料药获得上市申请批准通知书的公告》
华纳药厂最新公告:子公司西甲硅油原料药获上市批准
证券之星 · 08-24
华纳药厂最新公告:子公司西甲硅油原料药获上市批准
华纳药厂最新公告:子公司原料药项目投资额度增至8亿元
证券之星 · 08-24
华纳药厂最新公告:子公司原料药项目投资额度增至8亿元
8月20日华纳药厂涨5.31%,安信医药健康股票A基金重仓该股
证券之星 · 08-20
8月20日华纳药厂涨5.31%,安信医药健康股票A基金重仓该股
每周股票复盘:华纳药厂(688799)两款药品拟中选集采
证券之星 · 08-09
每周股票复盘:华纳药厂(688799)两款药品拟中选集采
股市必读:华纳药厂新发布《自愿披露关于公司参与全国药品集中采购拟中选的公告》
证券之星 · 08-05
股市必读:华纳药厂新发布《自愿披露关于公司参与全国药品集中采购拟中选的公告》
华纳药厂(688799)披露参与全国药品集中采购拟中选公告,8月3日股价上涨1.07%
证券之星 · 08-03
华纳药厂(688799)披露参与全国药品集中采购拟中选公告,8月3日股价上涨1.07%
华纳药厂(688799.SH):琥珀酸亚铁片等拟中选全国药品集中采购
智通财经 · 08-03
华纳药厂(688799.SH):琥珀酸亚铁片等拟中选全国药品集中采购
7月30日华纳药厂跌9.98%,安信医药健康股票A基金重仓该股
证券之星 · 07-30
7月30日华纳药厂跌9.98%,安信医药健康股票A基金重仓该股
加载更多
公司概况
公司名称:
湖南华纳大药厂股份有限公司
所属行业:
医药制造业
上市日期:
2021-07-13
主营业务:
湖南华纳大药厂股份有限公司的主营业务是化学药制剂、化学原料药和中药制剂的研发、生产与销售。公司的主要产品是胶体果胶铋干混悬剂、胶体果胶铋胶囊、枸橼酸铋钾胶囊、多库酯钠片、蒙脱石散、聚乙二醇4000散、吸入用乙酰半胱氨酸溶液、盐酸左沙丁胺醇雾化吸入溶液、吸入用硫酸沙丁胺醇溶液、吸入用异丙托溴铵溶液、富马酸福莫特罗吸入溶液、磷霉素氨丁三醇散、恩替卡韦颗粒、琥珀酸亚铁片、双氯芬酸钠缓释片、吗替麦考酚酯胶囊。
发行价格:
30.82
{"stockData":{"symbol":"688799","market":"SH","secType":"STK","nameCN":"华纳药厂","latestPrice":46.21,"timestamp":1789110001000,"preClose":46.94,"halted":0,"volume":1183299,"delay":0,"changeRate":-0.0156,"floatShares":134000000,"shares":134000000,"eps":1.7343,"marketStatus":"已收盘","change":-0.73,"latestTime":"09-11 15:00:01","open":46.96,"high":47,"low":45.74,"amount":54725400,"amplitude":0.0268,"askPrice":46.24,"askSize":2,"bidPrice":46.21,"bidSize":38,"shortable":0,"etf":0,"ttmEps":1.7343,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1789349400000},"marketStatusCode":5,"adr":0,"adjPreClose":46.94,"symbolType":"stock_kcb","openAndCloseTimeList":[[1789090200000,1789097400000],[1789102800000,1789110000000]],"highLimit":51.63,"lowLimit":42.25,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":133637000,"isCdr":false,"pbRate":2.91,"roa":"--","peRate":26.644756,"roe":"3.11%","epsLYR":1.81,"committee":-0.025974,"marketValue":6175000000,"turnoverRate":0.0089,"status":1,"nextConnectDate":"根据港交所公布的数据,今日已停止北向交易,下一个交易日为北京时间 2026-09-14。","afterMarket":{"amount":0,"volume":0,"close":46.21,"buyVolume":0,"sellVolume":0,"time":1789112037746,"indexStatus":"已收盘 09-11 15:30:00","preClose":46.94},"floatMarketCap":6175000000},"requestUrl":"/m/hq/s/688799","defaultTab":"news","newsList":[{"id":"2665391737","title":"华纳药厂:中信保诚基金管理有限公司、方正证券股份有限公司等多家机构于9月3日调研我司","url":"https://stock-news.laohu8.com/highlight/detail?id=2665391737","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665391737?lang=zh_cn&edition=full","pubTime":"2026-09-07 13:58","pubTimestamp":1788760698,"startTime":"0","endTime":"0","summary":"证券之星消息,2026年9月3日华纳药厂发布公告称中信保诚基金管理有限公司、方正证券股份有限公司于2026年9月3日调研我司。ZG-001胶囊是公司的参股公司上海致根医药科技有限公司自主开发的具有全新结构的新型抗抑郁药,属于化药1类创新药。ZG-001胶囊目前尚在开展Ⅱa期临床试验。具体情况及后续临床研究进展请见公司在上海证券交易所网站披露的公告。以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090700013554.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK1184","LU1880383366.USD","BK0122","LU1015430645.USD","BK0183","LU0048597586.USD","BK0276","688799","LU0575583348.USD","BK0012","BK0188","LU0251144936.SGD","601901","LU0211331839.USD","02378","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665651313","title":"每周股票复盘:华纳药厂(688799)获洛索洛芬钠贴剂注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2665651313","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665651313?lang=zh_cn&edition=full","pubTime":"2026-09-06 01:50","pubTimestamp":1788630620,"startTime":"0","endTime":"0","summary":"截至2026年9月4日收盘,华纳药厂报收于50.02元,较上周的44.36元上涨12.76%。本周,华纳药厂9月4日盘中最高价报50.68元。本次药品注册证书的取得丰富了公司制剂产品品种,对优化产品结构具有积极意义,但不会对公司近期业绩产生重大影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090600000397.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688799"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664996845","title":"股市必读:华纳药厂新发布《自愿披露关于子公司原料药获得上市申请批准通知书的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2664996845","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664996845?lang=zh_cn&edition=full","pubTime":"2026-09-03 02:07","pubTimestamp":1788372431,"startTime":"0","endTime":"0","summary":"公司公告汇总自愿披露关于子公司原料药获得上市申请批准通知书的公告湖南华纳大药厂股份有限公司全资子公司湖南华纳大药厂手性药物有限公司收到国家药品监督管理局签发的艾拉莫德《化学原料药上市申请批准通知书》,并在CDE原辅包登记信息平台公示。艾拉莫德为艾拉莫德片的原料药,用于治疗活动性类风湿关节炎。审批结论为符合药品注册有关要求,批准注册,质量标准、标签及生产工艺照所附执行。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090300001947.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688799","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664890104","title":"华纳药厂最新公告:子公司艾拉莫德原料药获上市批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2664890104","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664890104?lang=zh_cn&edition=full","pubTime":"2026-09-02 17:26","pubTimestamp":1788341213,"startTime":"0","endTime":"0","summary":"华纳药厂(688799.SH)公告称,公司全资子公司手性药物收到国家药监局签发的艾拉莫德《化学原料药上市申请批准通知书》,该原料药主要用于治疗活动性类风湿关节炎。此次获批将进一步丰富公司产品线,提升核心竞争力,但生产销售时间受GMP检查及市场环境影响存在不确定性。以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090200030877.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688799"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664635508","title":"股市必读:华纳药厂新发布《自愿披露关于获得药品注册证书的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2664635508","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664635508?lang=zh_cn&edition=full","pubTime":"2026-09-02 01:23","pubTimestamp":1788283390,"startTime":"0","endTime":"0","summary":"截至2026年9月1日收盘,华纳药厂报收于48.73元,上涨4.46%,换手率3.59%,成交量4.8万手,成交额2.3亿元。公司公告汇总自愿披露关于获得药品注册证书的公告湖南华纳大药厂股份有限公司收到国家药品监督管理局核准签发的洛索洛芬钠贴剂《药品注册证书》,该药品注册分类为化学药品4类,视同通过一致性评价。本次药品注册证书的取得丰富了公司制剂产品品种,对优化产品结构具有积极意义,但不会对公司近期业绩产生重大影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090200001852.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688799"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664007544","title":"股市必读:华纳药厂新发布《自愿披露关于获得药品注册证书的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2664007544","media":"证券之星","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664007544?lang=zh_cn&edition=full","pubTime":"2026-09-01 01:12","pubTimestamp":1788196332,"startTime":"0","endTime":"0","summary":"截至2026年8月31日收盘,华纳药厂报收于46.65元,上涨5.16%,换手率2.95%,成交量3.94万手,成交额1.79亿元。公司公告汇总自愿披露关于获得药品注册证书的公告湖南华纳大药厂股份有限公司收到国家药品监督管理局核准签发的洛索洛芬钠贴剂《药品注册证书》,该药品注册分类为化学药品4类,视同通过一致性评价。本次药品注册证书的取得丰富了公司制剂产品品种,对优化产品结构具有积极意义,但不会对公司近期业绩产生重大影响。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090100001808.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688799","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663727070","title":"华纳药厂最新公告:获得洛索洛芬钠贴剂药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2663727070","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663727070?lang=zh_cn&edition=full","pubTime":"2026-08-31 19:40","pubTimestamp":1788176433,"startTime":"0","endTime":"0","summary":"华纳药厂(688799.SH)公告称,公司收到国家药品监督管理局核准签发的洛索洛芬钠贴剂《药品注册证书》。该药品用于骨关节炎、肌肉痛、外伤导致的肿胀或疼痛的消炎和镇痛,按化学药品4类获批,视同通过一致性评价。此次获批进一步丰富公司制剂产品品种,对优化产品结构有积极意义,但不会对近期业绩产生重大影响。以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100031728.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688799","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663075963","title":"8月31日华纳药厂涨5.16%,安信医药健康股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2663075963","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663075963?lang=zh_cn&edition=full","pubTime":"2026-08-31 16:40","pubTimestamp":1788165650,"startTime":"0","endTime":"0","summary":"证券之星消息,8月31日华纳药厂涨5.16%,收盘报46.65元,换手率2.95%,成交量3.94万手,成交额1.79亿元。重仓华纳药厂的公募基金请见下表:根据2026基金半年报公募基金重仓股数据,重仓该股的公募基金共7家,其中持有数量最多的公募基金为安信基金的安信医药健康股票A。安信医药健康股票A的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100022345.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688799","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663100270","title":"每周股票复盘:华纳药厂(688799)Q2净利增26.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663100270","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663100270?lang=zh_cn&edition=full","pubTime":"2026-08-30 04:46","pubTimestamp":1788036370,"startTime":"0","endTime":"0","summary":"截至2026年8月28日收盘,华纳药厂报收于44.36元,较上周的43.65元上涨1.63%。本周,华纳药厂8月24日盘中最高价报45.98元。本周关注点来自业绩披露要点:2026年第二季度归母净利润3772.29万元,同比上升26.16%。股本股东变化截至2026年6月30日,华纳药厂股东户数为7530.0户,较3月31日减少824.0户,减幅9.86%。其中,2026年第二季度单季度主营收入3.36亿元,同比下降10.95%;单季度归母净利润3772.29万元,同比上升26.16%;单季度扣非净利润3225.47万元,同比上升38.13%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083000001450.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688799","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662738986","title":"华纳药厂(688799)6月30日股东户数0.75万户,较上期减少9.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662738986","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662738986?lang=zh_cn&edition=full","pubTime":"2026-08-25 17:42","pubTimestamp":1787650942,"startTime":"0","endTime":"0","summary":"证券之星消息,近日华纳药厂披露,截至2026年6月30日公司股东户数为7530.0户,较3月31日减少824.0户,减幅为9.86%。在化学制药行业个股中,华纳药厂股东户数低于行业平均水平,截至6月30日,化学制药行业平均股东户数为3.68万户。从股价来看,2026年3月31日至2026年6月30日,华纳药厂区间跌幅为18.4%,在此期间股东户数减少824.0户,减幅为9.86%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082500036902.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688799"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662034122","title":"图解华纳药厂中报:第二季度单季净利润同比增长26.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662034122","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662034122?lang=zh_cn&edition=full","pubTime":"2026-08-25 02:39","pubTimestamp":1787596778,"startTime":"0","endTime":"0","summary":"证券之星消息,华纳药厂2026年中报显示,上半年度公司主营收入6.61亿元,同比下降7.43%;归母净利润6459.98万元,同比下降9.16%;扣非净利润5872.09万元,同比下降0.73%;其中2026年第二季度,公司单季度主营收入3.36亿元,同比下降10.95%;单季度归母净利润3772.29万元,同比上升26.16%;单季度扣非净利润3225.47万元,同比上升38.13%;负债率38.24%,投资收益320.34万元,财务费用308.94万元,毛利率56.52%。财报数据概要请见下图:本文数据来源于华纳药厂2026年中报,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082500005554.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688799"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662120850","title":"股市必读:华纳药厂新发布《自愿披露关于子公司原料药获得上市申请批准通知书的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2662120850","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662120850?lang=zh_cn&edition=full","pubTime":"2026-08-25 01:00","pubTimestamp":1787590848,"startTime":"0","endTime":"0","summary":"公司公告汇总自愿披露关于子公司原料药获得上市申请批准通知书的公告湖南华纳大药厂股份有限公司全资子公司湖南华纳大药厂手性药物有限公司收到国家药品监督管理局签发的西甲硅油《化学原料药上市申请批准通知书》,并在CDE平台公示。本次批准表明该原料药符合国家药品注册要求,已获准在国内制剂中使用。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082500002658.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688799"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661780392","title":"华纳药厂最新公告:子公司西甲硅油原料药获上市批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2661780392","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661780392?lang=zh_cn&edition=full","pubTime":"2026-08-24 18:50","pubTimestamp":1787568655,"startTime":"0","endTime":"0","summary":"华纳药厂(688799.SH)公告称,公司全资子公司手性药物收到国家药监局签发的西甲硅油《化学原料药上市申请批准通知书》,该原料药已批准在国内制剂中使用,将进一步丰富公司产品线,提升核心竞争力。受GMP符合性检查进度及市场环境影响,生产销售时间存在不确定性。以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082400027475.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688799","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661722278","title":"华纳药厂最新公告:子公司原料药项目投资额度增至8亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2661722278","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661722278?lang=zh_cn&edition=full","pubTime":"2026-08-24 18:50","pubTimestamp":1787568652,"startTime":"0","endTime":"0","summary":"华纳药厂(688799.SH)公告称,公司审议通过子公司致根制药“年产3000吨高端原料药及中间体绿色智造基地(一期)建设项目”投资额度由不超过6.5亿元增加至不超过8亿元。该项目位于长沙市望城区,目前土建工程已基本完成,部分车间已进入试生产阶段。本次增加投资基于项目建设需要及市场形势,资金来源为自有及自筹资金,不涉及关联交易,无需提交股东会审议。以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082400027478.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688799"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660402768","title":"8月20日华纳药厂涨5.31%,安信医药健康股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2660402768","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660402768?lang=zh_cn&edition=full","pubTime":"2026-08-20 16:39","pubTimestamp":1787215158,"startTime":"0","endTime":"0","summary":"证券之星消息,8月20日华纳药厂涨5.31%,收盘报45.24元,换手率3.57%,成交量4.77万手,成交额2.17亿元。重仓华纳药厂的公募基金请见下表:根据2026基金半年报公募基金重仓股数据,重仓该股的公募基金共7家,其中持有数量最多的公募基金为安信基金的安信医药健康股票A。安信医药健康股票A的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082000028914.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688799","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658813675","title":"每周股票复盘:华纳药厂(688799)两款药品拟中选集采","url":"https://stock-news.laohu8.com/highlight/detail?id=2658813675","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658813675?lang=zh_cn&edition=full","pubTime":"2026-08-09 02:20","pubTimestamp":1786213224,"startTime":"0","endTime":"0","summary":"截至2026年8月7日收盘,华纳药厂报收于47.03元,较上周的42.0元上涨11.98%。本周,华纳药厂8月7日盘中最高价报47.2元。华纳药厂当前最新总市值62.85亿元,在化学制药板块市值排名80/149,在两市A股市值排名2638/5205。琥珀酸亚铁片2025年销售收入8,945.50万元,占营业收入5.95%;双氯芬酸钠缓释片2025年销售收入8,936.05万元,占营业收入5.94%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080900000640.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688799","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657556871","title":"股市必读:华纳药厂新发布《自愿披露关于公司参与全国药品集中采购拟中选的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2657556871","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657556871?lang=zh_cn&edition=full","pubTime":"2026-08-05 01:20","pubTimestamp":1785864024,"startTime":"0","endTime":"0","summary":"截至2026年8月4日收盘,华纳药厂报收于44.26元,上涨4.26%,换手率2.25%,成交量3.0万手,成交额1.32亿元。公司公告汇总:华纳药厂琥珀酸亚铁片、双氯芬酸钠缓释片拟中选第十二批全国药品集采,两产品2025年合计营收占比约11.89%。公司公告汇总自愿披露关于公司参与全国药品集中采购拟中选的公告2026年7月31日,湖南华纳大药厂股份有限公司参加第十二批全国药品集中采购投标,琥珀酸亚铁片和双氯芬酸钠缓释片拟中选。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080500001587.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688799","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656377818","title":"华纳药厂(688799)披露参与全国药品集中采购拟中选公告,8月3日股价上涨1.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2656377818","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656377818?lang=zh_cn&edition=full","pubTime":"2026-08-03 22:17","pubTimestamp":1785766652,"startTime":"0","endTime":"0","summary":"截至2026年8月3日收盘,华纳药厂报收于42.45元,较前一交易日上涨1.07%,最新总市值为56.73亿元。公告显示,2026年7月31日,公司参加了第十二批全国药品集中采购投标,琥珀酸亚铁片和双氯芬酸钠缓释片拟中选。琥珀酸亚铁片2025年销售收入8,945.50万元,占营业收入5.95%;双氯芬酸钠缓释片2025年销售收入8,936.05万元,占营业收入5.94%。两产品拟中选价格分别为10.63元/盒和11.88元/盒,采购周期至2029年12月31日。公告同时提示,后续合同签订存在不确定性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080300037119.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688799","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656537404","title":"华纳药厂(688799.SH):琥珀酸亚铁片等拟中选全国药品集中采购","url":"https://stock-news.laohu8.com/highlight/detail?id=2656537404","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656537404?lang=zh_cn&edition=full","pubTime":"2026-08-03 21:45","pubTimestamp":1785764723,"startTime":"0","endTime":"0","summary":"智通财经APP讯,华纳药厂(688799.SH)发布公告,2026年7月31日,公司参加了国家组织药品联合采购办公室组织的第十二批全国药品集中采购的投标工作,公司琥珀酸亚铁片、双氯芬酸钠缓释片拟中选本次集中采购。本次集中采购是联合采购办公室组织的第十二批全国药品集中采购,采购周期中,医疗机构将优先使用中选药品,并确保完成约定采购量。公司上述产品本次拟中选价格与原销售价格相比有一定程度下降,若公司后续签订采购合同并执行后,将有利于上述产品扩充合作渠道,促进国内市场的开拓,提升公司的品牌影响力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1475473.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","688799"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655824289","title":"7月30日华纳药厂跌9.98%,安信医药健康股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2655824289","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655824289?lang=zh_cn&edition=full","pubTime":"2026-07-30 16:46","pubTimestamp":1785401191,"startTime":"0","endTime":"0","summary":"证券之星消息,7月30日华纳药厂跌9.98%创60日新低,收盘报40.7元,换手率3.78%,成交量5.05万手,成交额2.14亿元。重仓华纳药厂的公募基金请见下表:根据2026基金半年报公募基金重仓股数据,重仓该股的公募基金共7家,其中持有数量最多的公募基金为安信基金的安信医药健康股票A。安信医药健康股票A的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026073000026100.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688799","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1789159018492,"stockEarnings":[{"period":"1week","weight":-0.0762},{"period":"1month","weight":0.0068},{"period":"3month","weight":-0.0284},{"period":"6month","weight":0.069},{"period":"1year","weight":-0.2016},{"period":"ytd","weight":-0.0274}],"compareEarnings":[{"period":"1week","weight":-0.0107},{"period":"1month","weight":-0.0148},{"period":"3month","weight":-0.0356},{"period":"6month","weight":-0.0506},{"period":"1year","weight":0.0033},{"period":"ytd","weight":-0.0203}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"湖南华纳大药厂股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"7530人(较上一季度减少9.86%)","perCapita":"17747股","listingDate":"2021-07-13","address":"湖南省长沙市浏阳市生物医药园区","registeredCapital":"13363万元","survey":" 湖南华纳大药厂股份有限公司的主营业务是化学药制剂、化学原料药和中药制剂的研发、生产与销售。公司的主要产品是胶体果胶铋干混悬剂、胶体果胶铋胶囊、枸橼酸铋钾胶囊、多库酯钠片、蒙脱石散、聚乙二醇4000散、吸入用乙酰半胱氨酸溶液、盐酸左沙丁胺醇雾化吸入溶液、吸入用硫酸沙丁胺醇溶液、吸入用异丙托溴铵溶液、富马酸福莫特罗吸入溶液、磷霉素氨丁三醇散、恩替卡韦颗粒、琥珀酸亚铁片、双氯芬酸钠缓释片、吗替麦考酚酯胶囊。","listedPrice":30.82},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"华纳药厂(688799)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供华纳药厂(688799)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"华纳药厂,688799,华纳药厂股票,华纳药厂股票老虎,华纳药厂股票老虎国际,华纳药厂行情,华纳药厂股票行情,华纳药厂股价,华纳药厂股市,华纳药厂股票价格,华纳药厂股票交易,华纳药厂股票购买,华纳药厂股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"华纳药厂(688799)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供华纳药厂(688799)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}